Insiders · Profile

Haas Jason

Director at LIGAND PHARMACEUTICALS · Chief Financial Officer at Odyssey Therapeutics. Filing since 8 May 2026. CIK 0001883821

Company

Date

Role

Action

Amount

Of holding

12 Aug 2026

Director

Sold at will

7,138

$2.09M

64.2%

12 Jun 2026

Director

Sold at will

6,461

$1.65M

56.5%

8 May 2026

Chief Financial Officer

Bought

1,000

$20.00K

1.6%

3 decisions on file.